EDDA Technology

EDDA Technology

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $45M

Overview

EDDA Technology is an innovative leader in computer-assisted radiology and surgery, focusing on precision oncology. Its core IQQA® platform leverages AI and machine learning to transform standard 2D CT and MRI scans into interactive, quantitative 3D models, enabling detailed surgical planning and real-time navigation. The company's solutions are commercial-stage, deployed in hospitals to support complex procedures like liver resections, lung segmentectomies, and kidney partial nephrectomies. By targeting the growing field of image-guided precision surgery, EDDA seeks to establish a standard of care in surgical oncology and interventional radiology.

OncologySurgical OncologyInterventional Radiology

Technology Platform

IQQA® platform: An AI/ML-driven software suite for fully quantitative, real-time interactive 3D medical image analysis, segmentation, surgical planning/simulation, and intra-operative navigation. It transforms 2D CT/MRI into patient-specific 3D models for liver, lung, and kidney procedures.

Funding History

3
Total raised:$45M
Series C$20M
Series B$15M
Series A$10M

Opportunities

The global shift towards minimally invasive, organ-preserving cancer surgery creates a strong demand for precise 3D planning tools.
Expansion into new anatomical sites (e.g., pancreas, prostate) and deeper integration with robotic surgery platforms present significant growth avenues.
Strategic partnerships with large medtech companies for distribution could accelerate market penetration.

Risk Factors

Key risks include slow hospital adoption and long sales cycles, competition from large, integrated medtech players, and the challenge of securing consistent reimbursement from payers for software-based surgical planning.
Technological risks involve ensuring the AI models' accuracy and robustness across diverse patient anatomies and imaging qualities.

Competitive Landscape

EDDA competes with large medical imaging and navigation companies like Medtronic (StealthStation), Johnson & Johnson (Cerenovus, Verb Surgical), and Siemens Healthineers, which offer integrated hardware-software solutions. It also faces competition from other AI-powered surgical planning startups such as Therenva, Intuitive Surgical (with its integrated planning), and specialized software firms in radiology AI. EDDA's differentiation lies in its organ-specific, quantitative, end-to-end platform focused purely on enabling complex cancer surgeries.